Epithelial Malignancies的临床试验
总计22501个结果
-
University of California, Davis完全的
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
Kite, A Gilead Company邀请报名
-
M.D. Anderson Cancer Center尚未招聘
-
Shanghai Escugen Biotechnology Co., LtdEscugen (Australia) Biotechnology Pty Ltd尚未招聘B 细胞淋巴恶性肿瘤
-
Shanghai Junshi Bioscience Co., Ltd.CTI Clinical Trial and Consulting Services; TopAlliance Biosciences, Inc.撤销恶性肿瘤 | 以前治疗过,高级
-
Eisai Inc.完全的
-
M.D. Anderson Cancer CenterReata Pharmaceuticals, Inc.完全的
-
Senti Biosciences招聘中反洗钱/材料数据表 | CD33 表达血液恶性肿瘤 | FLT3 表达血液恶性肿瘤美国, 澳大利亚
-
Washington University School of Medicine招聘中
-
AstraZenecaParexel主动,不招人
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine完全的
-
Centre Hospitalier Universitaire de Besancon终止
-
Millennium Pharmaceuticals, Inc.完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Novartis Pharmaceuticals; Brigham...终止
-
Novartis Pharmaceuticals完全的
-
Millennium Pharmaceuticals, Inc.完全的Advanced Non-hematologic Malignancies美国, 加拿大
-
SCRI Development Innovations, LLCNovartis完全的
-
National Taiwan University Hospital尚未招聘复发/难治性 B 细胞恶性肿瘤
-
Anand B. Karnad完全的Advanced B-cell Lymphoid Malignancies美国
-
CASI Pharmaceuticals, Inc.完全的
-
King Faisal Specialist Hospital & Research Center完全的